What is Impact BioMedical, Inc.'s Market Cap?

Impact BioMedical, Inc.'s Market Cap is $53.9M, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s Enterprise Value?

Impact BioMedical, Inc.'s Enterprise Value is $53.9M, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s Trailing P/E?

Impact BioMedical, Inc.'s Trailing P/E is 68.2×, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s Price / Sales?

Impact BioMedical, Inc.'s Price / Sales is 1540.3×, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s EV / Revenue?

Impact BioMedical, Inc.'s EV / Revenue is 1540.0×, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s EV / EBITDA?

Impact BioMedical, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s Revenue (TTM)?

Impact BioMedical, Inc.'s Revenue (TTM) is $35.0K, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s Net Income (TTM)?

Impact BioMedical, Inc.'s Net Income (TTM) is $791.0K, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s EBITDA?

Impact BioMedical, Inc.'s EBITDA is -$4.0M, based on as-reported figures from SEC (XBRL) filings.

What is Impact BioMedical, Inc.'s Diluted EPS (TTM)?

Impact BioMedical, Inc.'s Diluted EPS (TTM) is 0.01, based on as-reported figures from SEC (XBRL) filings.

Impact BioMedical, Inc. (IBO) Financial Statements

Impact BioMedical, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01JFZG023

XASE · usd

0.50▲ 0.00 (0.00%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.50

Day's Range0.50 – 0.53

52-Week Range0.37 – 0.83

Volume146.8K

Avg Volume171.1K

Share Statistics

Shares Outstanding

Employees8

ExchangeXASE

Listed2024-09-16

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Impact BioMedical, Inc. (IBO)

What is Impact BioMedical, Inc.'s Market Cap?: Impact BioMedical, Inc.'s Market Cap is $53.9M, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Enterprise Value?: Impact BioMedical, Inc.'s Enterprise Value is $53.9M, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Trailing P/E?: Impact BioMedical, Inc.'s Trailing P/E is 68.2×, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Price / Sales?: Impact BioMedical, Inc.'s Price / Sales is 1540.3×, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s EV / Revenue?: Impact BioMedical, Inc.'s EV / Revenue is 1540.0×, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s EV / EBITDA?: Impact BioMedical, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Revenue (TTM)?: Impact BioMedical, Inc.'s Revenue (TTM) is $35.0K, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Net Income (TTM)?: Impact BioMedical, Inc.'s Net Income (TTM) is $791.0K, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s EBITDA?: Impact BioMedical, Inc.'s EBITDA is -$4.0M, based on as-reported figures from SEC (XBRL) filings.
What is Impact BioMedical, Inc.'s Diluted EPS (TTM)?: Impact BioMedical, Inc.'s Diluted EPS (TTM) is 0.01, based on as-reported figures from SEC (XBRL) filings.